Home » Newsletters » BioWorld

BioWorld

Sep. 29, 1993

View Archived Issues

PEAT MARWICK SURVEY: SWISS LEADING FOREIGN INVESTORS

IPI INKS $11M PACT WITH EISAI

LIDAK TO TRADE ON NASDAQ

TLC DISTRIBUTES ABLC IN SOUTH AFRICA

MERIDIAN COMPLETES OFFERING

LEDERLE FUNDS IMCLONE RESEARCH

XENOGRAFT CONFERENCE: PIGS FAVORED AS ORGAN DONORS

CLINTON ADAMANT ABOUT RESTRAINING DRUG COSTS

AVIGEN ACQUIRES RIGHTS TO MULTIDRUG RESISTANCE GENE

ALEXION LICENSES PORCINE EMBRYONIC STEM CELLS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...